CARINH and inflammatory bowel disease: Our studies of CARINH corroborate other reports that this lncRNA is an IFN-responsive gene in models of cancer (Huang et al, 2019) and inflammatory bowel disease (Ma et al, 2023; Johnson et al, 2024).